The Discounted Cash Flow (DCF) valuation of CASI Pharmaceuticals Inc (CASI) is (98.32) USD. With the latest stock price at 1.81 USD, the upside of CASI Pharmaceuticals Inc based on DCF is -5532.3%.
Based on the latest price of 1.81 USD and our DCF valuation, CASI Pharmaceuticals Inc (CASI) is a sell. selling CASI stocks now will result in a potential gain of 5532.3%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 6.9% | 6.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (372.73) - (58.30) | (98.32) |
| Upside | -20692.6% - -3320.9% | -5532.3% |